What’s more, growing studies have reported that the immune-related features of cancers such as the intensity of CD4+ T cells and CD8+ T cell infiltrates, macrophages, and natural killer (NK) cells, different B cell sub-populations were correlated with immunotherapeutic responsiveness in lung cancer (Stankovic et al., 2018). The gene discussed is CD4; the disease is lung carcinoma.